How to come off Mounjaro: making the right call for you

What your body does when you stop taking tirzepatide

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, that together reduce appetite, slow gastric emptying and help regulate blood sugar. While the medicine is active, those signals are continuously reinforced. Stop the injections, and they fade over the following days and weeks as the drug clears your system.

For most people, the first thing they notice is hunger coming back. Not dramatically, in most cases, but hunger that felt manageable on treatment can feel more insistent once the hormonal support is gone. Cravings, appetite variability and food noise often return to something closer to pre-treatment levels. The NHS tirzepatide medicines page notes that Mounjaro is intended for use alongside a reduced-calorie diet and increased physical activity; those foundations matter more, not less, once the medicine stops.

Weight regain is real and well-documented. Data from the SURMOUNT clinical programme showed that participants who stopped tirzepatide regained a meaningful portion of their lost weight over the following months. That is not a reason to stay on the medicine indefinitely if it is no longer right for you, but it is a reason to have a clear plan before you stop rather than deciding on a Tuesday because your pen has run out.

The decision to stop: what actually drives it

There are several legitimate reasons someone might want to come off Mounjaro, and they are not all equal in urgency. A prescriber will think about them differently depending on which applies to you.

Some people stop because they have reached a weight and health outcome they are satisfied with and want to see whether they can maintain it without treatment. That is a reasonable goal; the question is whether you have the lifestyle structures in place to support it. Others stop because of side effects, persistent nausea, gastrointestinal discomfort or other symptoms that have not settled with time or dose adjustment. That conversation should happen sooner rather than later; there may be options (a dose reduction, for example) before outright stopping. Some people stop for financial reasons, or because they are planning a pregnancy, since Mounjaro is not recommended during pregnancy or while breastfeeding. And some stop because a prescriber recommends it, for instance, if less than five per cent weight loss has been achieved at the highest tolerated dose after six months, as outlined in NICE's appraisal of tirzepatide (TA1026).

The timing matters in practical terms too. If you are stopping for non-urgent reasons, a quiet period works better than a high-stress week or a holiday with unpredictable eating patterns, the first few weeks are when the return of appetite tends to be most noticeable.

Should you taper the dose or stop at the dose you are on?

This is one of the questions our prescribers hear most often, and the honest answer is: it depends on the individual. There is no single protocol written into the Mounjaro SmPC that mandates a specific taper. The decision is clinical. A prescriber might suggest stepping down gradually from a higher dose to reduce the abruptness of appetite changes, or they might advise stopping at your current dose if you are already at a lower strength. What they will not do is simply cut you off without a conversation.

If you are weighing up your options and curious about whether Mounjaro comes in pill form, it is worth knowing that tirzepatide is currently only licensed as an injection in the UK, and if you have also wondered whether Mounjaro comes in tablet form, the answer is the same, since no oral version is currently available. For a broader overview of the treatment itself, the Mounjaro treatment page covers how it works and what the licensed schedule looks like.

A structured stopping plan, drawn up with your prescriber, should also include what support is in place for the weeks that follow. That might be dietary changes, activity goals or an agreed check-in to see how you are managing.

What a clinical review before stopping actually covers

Stopping a prescription medicine is just as much a clinical event as starting one. A review before you come off Mounjaro gives your prescriber the chance to look at your current weight, any health conditions that were part of the original treatment rationale, and whether your reasons for stopping are ones that might be addressed another way.

At nume, a real clinician reviews your case (not a form submitted into a void) and that applies to stopping conversations as much as starting ones. If you are wondering what ongoing support looks like, the FAQs page covers the aftercare structure, and you can read more about our clinical team on the clinical team profile. For people who are pausing treatment rather than stopping permanently, there is a separate question around whether you can come straight off Mounjaro or whether a more gradual approach is advisable, which the dedicated stopping guide covers in more detail, including the distinction between a planned pause and an unplanned one.

If you are at an earlier stage and still deciding whether treatment is right for you at all, the weight-loss treatment overview sets out the options available through nume, and if you would like some background on the medicine's history, our page on when Mounjaro came out explains how and when it became available in the UK. And if you are ready to speak to a prescriber about your current treatment, including how to stop safely, you can start a free consultation and a GPhC-registered prescriber will review your case the same day.